BRAF and thyroid gland carcinoma: In this regard, we used the BRAF mRNA expression level as a surrogate marker for Braf function in thyroid carcinoma, although a substantial proportion of variation in the protein level cannot be explained wholly by changes in the mRNA level alone [25].